EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSUPAG00010007637
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSUPAG00010009604
Gene Symbol: TUBA1B
1 Cross references
193 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSUPAG00010009626
Gene Symbol: TUBA1C
1 Cross references
119 Possible Orthologues:

Tubulin Alpha 3e

Ensembl ID : ENSUPAG00010013061
Gene Symbol: TUBA3E
3 Cross references
167 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSUPAG00010012836
Gene Symbol: TUBA4A
1 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSUPAG00010012345
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSUPAG00010010579
Gene Symbol: TUBB2B
3 Cross references
151 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSUPAG00010023665
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSUPAG00010006033
Gene Symbol: TUBB4B
3 Cross references
315 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSUPAG00010020929
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSUPAG00010003937
Gene Symbol: TUBB
1 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSUPAG00010015398
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).